| MeSH term | MeSH ID | Detail |
|---|---|---|
| Bartter Syndrome | D001477 | 5 associated lipids |
| Behcet Syndrome | D001528 | 7 associated lipids |
| Biliary Tract Neoplasms | D001661 | 7 associated lipids |
| Birth Weight | D001724 | 23 associated lipids |
| Blister | D001768 | 16 associated lipids |
| Blood Platelet Disorders | D001791 | 12 associated lipids |
| Bluetongue | D001819 | 1 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Bronchial Spasm | D001986 | 18 associated lipids |
| Bronchitis | D001991 | 6 associated lipids |
Thromboxane b2
Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.
Cross Reference
Introduction
To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Thromboxane b2?
Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Thromboxane b2
PubChem Associated disorders and diseases
What pathways are associated with Thromboxane b2
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Thromboxane b2?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Thromboxane b2?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
What genes are associated with Thromboxane b2?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Thromboxane b2
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Aibiki M and Cook JA | Ulinastatin, a human trypsin inhibitor, inhibits endotoxin-induced thromboxane B2 production in human monocytes. | 1997 | Crit. Care Med. | pmid:9118658 |
| Shinohara M et al. | [Responses to surgical stress in blood coagulation and fibrinolysis, platelet counts and thromboxane B2 after esophageal cancer operation]. | 1997 | Rinsho Byori | pmid:9121003 |
| Teraoka S et al. | Multicenter trial of the therapeutic effect of a newly developed antiplatelet agent, satigrel, on biopsy-proven chronic rejection after kidney transplantation. | 1997 Feb-Mar | Transplant. Proc. | pmid:9122990 |
| Ishine N et al. | Hemodynamic analysis of post-reperfusion syndrome and the effect of preventing this syndrome using thromboxane A2 synthetase inhibitor (OKY-046) in swine liver transplantation. | 1997 Feb-Mar | Transplant. Proc. | pmid:9123045 |
| Suehiro T et al. | Value of caval effluent in predicting early graft function after orthotopic liver transplantation. | 1997 Feb-Mar | Transplant. Proc. | pmid:9123086 |
| Yagi T et al. | Hepatropic soluble vitamin E derivative EPC-K1 prevents warm ischemia/reperfusion injury of non-heart-beating donor liver transplantation in pigs. | 1997 Feb-Mar | Transplant. Proc. | pmid:9123352 |
| Cheng Z et al. | Pharmacokinetic and pharmacodynamic studies on phenylbutazone and oxyphenbutazone in goats. | 1997 | Vet. Rec. | pmid:9123796 |
| He CF et al. | Postural vasoregulation and mediators of reperfusion injury in venous ulceration. | 1997 | J. Vasc. Surg. | pmid:9129619 |
| Oelkers R et al. | Disposition and effects of flurbiprofen enantiomers in human serum and blister fluid. | 1997 | Br J Clin Pharmacol | pmid:9131946 |
| Olson KR et al. | Cardiovascular effects of homologous bradykinin in rainbow trout. | 1997 | Am. J. Physiol. | pmid:9140009 |
| Todd MK et al. | Comparison of methods for evaluating exercise-induced changes in thromboxane B2 and beta-thromboglobulin. | 1997 | Med Sci Sports Exerc | pmid:9140910 |
| Henrion D et al. | Alteration of flow-induced dilatation in mesenteric resistance arteries of L-NAME treated rats and its partial association with induction of cyclo-oxygenase-2. | 1997 | Br. J. Pharmacol. | pmid:9146891 |
| Riendeau D et al. | Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. | 1997 | Br. J. Pharmacol. | pmid:9146894 |
| Bishop-Bailey D et al. | Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture. | 1997 | Br. J. Pharmacol. | pmid:9146896 |
| Roberts LJ et al. | Metabolism of thromboxane B2 in man. Identification of the major urinary metabolite. | 1977 | J. Biol. Chem. | pmid:914816 |
| Kraft M et al. | The effect of salmeterol on nocturnal symptoms, airway function, and inflammation in asthma. | 1997 | Chest | pmid:9149578 |
| Zhang T et al. | Effects of the incubation of long-chain polyunsaturated fatty acids on platelet lipids and thromboxane release. | 1997 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:9150370 |
| Sinzinger H et al. | PGE1-induced arterial thromboresistance is a vascular property as identified by cross-perfusion technique. | 1997 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:9150379 |
| Closa D et al. | Prostanoids and free radicals in Cl4C-induced hepatotoxicity in rats: effect of astilbin. | 1997 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:9150380 |
| Shimada Y et al. | Role of platelets in myocardial ischemia-reperfusion injury in dogs. | 1997 | Jpn. Circ. J. | pmid:9152773 |